Mounjaro®
Starting from £179.99/mo
Start journey Learn moreYes, most people do regain some weight after stopping Wegovy, but the picture is more nuanced than a simple yes. Clinical trials show that adults who discontinue semaglutide gradually regain a significant portion of the weight they lost, typically over the following year — not overnight, and not always all of it. Wegovy is a prescription-only medicine requiring clinical assessment; any decision to stop should be made with your prescriber, not unilaterally.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
A lot of people fear that skipping one pen, or finishing a course, will trigger immediate rebound. That's not how it works. Semaglutide has a half-life of roughly a week, so its effects taper rather than vanish. In the first few weeks after stopping you may notice hunger returning gradually, food feeling less filling, and portions creeping up, but that shift takes time to translate into measurable weight change.
What the evidence actually shows is a slower, sustained pattern. The STEP 4 withdrawal study, published in the New England Journal of Medicine, followed adults who had lost weight on 2.4mg semaglutide and then switched to placebo. Over 48 weeks after stopping, participants regained on average around two-thirds of the weight they had originally lost. Crucially, most of the regain happened progressively across that year, not in the first fortnight. You have time to respond.
The honest version of events: stopping doesn't reset you to your starting point on day one, but without changing anything else, body weight does tend to trend back up. Understanding that timeline is the first step toward doing something about it. If you're curious what the weight-loss trajectory looks like while on treatment, our page on whether you'll lose weight on Wegovy covers the trial data in detail.
This is the part that gets glossed over, and it deserves plain language. Obesity is a chronic condition driven partly by hormones and appetite-regulation pathways in the brain and gut. Semaglutide works by activating GLP-1 receptors, slowing gastric emptying and reducing hunger signals, and the NHS patient information for semaglutide explains this mechanism clearly. When you stop the medicine, those signals return. Your body's set-point, the weight it defends, doesn't change just because you lost weight on treatment.
There's also a subtler effect: people who have lost significant weight on Wegovy often find their metabolism has adjusted, burning fewer calories at rest than before. This is a known physiological response to weight loss itself, independent of the medicine. It means that eating the same amount as someone who never gained weight can still lead to gradual regain.
None of this is a moral failing. It's the same reason someone with high blood pressure sees their readings climb when they stop antihypertensives. Chronic conditions often require ongoing management. That framing matters, and it's one a lot of people tell us they wish they'd heard at the start, you can read more reflections like that on our page about what to know before starting Wegovy.
If you're planning to stop, or your prescription is ending, a conversation with a prescriber before the last pen is the most useful thing you can do. A planned approach (sometimes called a tapering strategy) combined with a realistic diet and activity plan gives you the best chance of holding onto as much of your progress as possible. Our clinical team has written specifically about stopping Wegovy without gaining the weight back, and there's more detail on the relationship between stopping and weight gain if you want the full picture.
Practically, the things that help most are building habits around protein-rich meals (which slow digestion and support fullness even without the medicine), consistent physical activity, and continuing to weigh yourself regularly so trends don't sneak up. None of these replace the medicine, but they do narrow the gap. For some people, the right answer is continuing treatment long-term rather than stopping, and for others, the goal was always a time-limited course. There's no universal right answer, which is exactly why this decision belongs in a clinical conversation.
On the cost side, if price is part of what's driving a decision to stop, a Wegovy price comparison is worth reading before you make a final call, understanding what different services include can change the calculation.
If you're at the point where stopping feels right and you want to plan it properly, speak to our prescribers through a free consultation. A GPhC-registered clinician, not software, reads every submission the same day.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.